These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30339234)

  • 1. Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.
    Evenepoel P; Claes K; Meijers B; Laurent MR; Bammens B; Naesens M; Sprangers B; Cavalier E; Kuypers D
    Nephrol Dial Transplant; 2020 Apr; 35(4):697-705. PubMed ID: 30339234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
    Evenepoel P; Claes K; Meijers B; Laurent MR; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D
    Kidney Int; 2019 Jun; 95(6):1461-1470. PubMed ID: 30922664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Bone Histomorphometry after Kidney Transplantation.
    Keronen S; Martola L; Finne P; Burton IS; Kröger H; Honkanen E
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):894-903. PubMed ID: 31088851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study.
    Heimgartner N; Graf N; Frey D; Saleh L; Wüthrich RP; Bonani M
    Kidney Blood Press Res; 2020; 45(5):758-767. PubMed ID: 32998144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.
    Evenepoel P; Behets GJ; Viaene L; D'Haese PC
    Kidney Int; 2017 Feb; 91(2):469-476. PubMed ID: 27998642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
    Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
    Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
    Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational Study to Evaluate the Effect of Epidural Steroid Injection on Bone Mineral Density and Bone Turnover Markers.
    Jain A; Gupta P; Chaurasia R; Singh M; Pandey S
    Pain Physician; 2020 Sep; 23(5):E517-E524. PubMed ID: 32967402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural History of Bone Disease following Kidney Transplantation.
    Jørgensen HS; Behets G; Bammens B; Claes K; Meijers B; Naesens M; Sprangers B; Kuypers DRJ; Cavalier E; D'Haese P; Evenepoel P
    J Am Soc Nephrol; 2022 Mar; 33(3):638-652. PubMed ID: 35046132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: cross-sectional study.
    Kusec V; Smalcelj R; Cvijetić S; Rozman B; Skreb F
    Croat Med J; 2000 Dec; 41(4):396-400. PubMed ID: 11063762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of alendronate sodium (Fosamax) to ameliorate osteoporosis in renal transplant patients: a case-control study.
    Huang WH; Lee SY; Weng CH; Lai PC
    PLoS One; 2012; 7(11):e48481. PubMed ID: 23185261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.
    Evenepoel P; Claes K; Meijers B; Laurent M; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D
    J Bone Miner Res; 2019 Feb; 34(2):262-269. PubMed ID: 30427544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients.
    Bonani M; Meyer U; Frey D; Graf N; Bischoff-Ferrari HA; Wüthrich RP
    Kidney Blood Press Res; 2016; 41(5):614-622. PubMed ID: 27622692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
    Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
    Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term stability of bone mineral density in patients with renal transplant treated with cyclosporine and low doses of corticoids. Protective role of cyclosporine?].
    Ezaitouni F; Westeel PF; Fardellone P; Mazouz H; Brazier M; el Esper I; Sebert JL; Petit J; Westeel A; Pruna A; Fournier A
    Presse Med; 1998 Apr; 27(15):705-12. PubMed ID: 9767908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study.
    Aroldi A; Tarantino A; Montagnino G; Cesana B; Cocucci C; Ponticelli C
    Transplantation; 1997 Feb; 63(3):380-6. PubMed ID: 9039927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton.
    Iyer SP; Nikkel LE; Nishiyama KK; Dworakowski E; Cremers S; Zhang C; McMahon DJ; Boutroy S; Liu XS; Ratner LE; Cohen DJ; Guo XE; Shane E; Nickolas TL
    J Am Soc Nephrol; 2014 Jun; 25(6):1331-41. PubMed ID: 24511131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.
    Kanaan N; Claes K; Devogelaer JP; Vanderschueren D; Depresseux G; Goffin E; Evenepoel P
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1887-92. PubMed ID: 20634326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab.
    Kobel C; Frey D; Graf N; Wüthrich RP; Bonani M
    Kidney Blood Press Res; 2019; 44(5):1285-1293. PubMed ID: 31614356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.